Finance

Lists
AEON:NYSEAMERICAN
Aeon Biopharma Inc
0,31 US$
+0,82%
(+0,0026) 1D
8 ოქტ, 15:22:19 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AEON...
Open
0,31 US$
High
0,32 US$
Low
0,29 US$
Mkt. cap
15,64 მლნ.
Avg. vol.
13,25 მლნ.
Volume
829,26 ათ.
52-wk high
1,45 US$
52-wk low
0,18 US$
EPS
-3,58 US$
Beta
0,69
Shares outstanding
49,88 მლნ.
No. of employees
8
Open
0,31 US$
High
0,32 US$
Low
0,29 US$
Mkt. cap
15,64 მლნ.
Avg. vol.
13,25 მლნ.
Volume
829,26 ათ.
52-wk high
1,45 US$
52-wk low
0,18 US$
EPS
-3,58 US$
Beta
0,69
Shares outstanding
49,88 მლნ.
No. of employees
8
News stories
From web sources and news partners
Profile
Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology. Wikipedia
About Aeon Biopharma Inc
CEOმურთი სიმჰამბატლა
Employees8
Founded2013
Headquartersირვაინი, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
597,00 ათ.
1,61 მლნ.
2,03 მლნ.
2,94 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,33 მლნ.
3,49 მლნ.
3,90 მლნ.
2,99 მლნ.
Operating expense
2,93 მლნ.
5,10 მლნ.
5,94 მლნ.
5,93 მლნ.
Total operating expenses
2,93 მლნ.
5,10 მლნ.
5,94 მლნ.
5,93 მლნ.
Operating income
-2,93 მლნ.
-5,10 მლნ.
-5,94 მლნ.
-5,93 მლნ.
Other non operating income
-168,00 ათ.
-14,08 მლნ.
2,94 მლნ.
4,98 მლნ.
EBT including unusual items
-4,54 მლნ.
-37,14 მლნ.
-11,79 მლნ.
-1,16 მლნ.
EBT excluding unusual items
-3,10 მლნ.
-19,18 მლნ.
-2,99 მლნ.
-952,00 ათ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,54 მლნ.
-37,14 მლნ.
-11,79 მლნ.
-1,16 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,39
-3,72
-0,25
-0,02
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,91 მლნ.
-5,08 მლნ.
-5,92 მლნ.
-5,91 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები